Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Canaccord Genuity maintained its Buy rating and $164.00 price target on Neurocrine Biosciences (NASDAQ:NBIX) following the company's fourth-quarter 2025 results. The firm highlighted robust performance from both Ingrezza and the recently launched Crenessity, while flagging higher-than-expected expenses and a lack of near-term pipeline catalysts as …
Canaccord Genuity increased its price target for SharkNinja (SN) to $160 from $140 and kept a Buy rating after the company reported fourth-quarter and full-year results that beat key consensus metrics. SharkNinja delivered solid revenue and margin performance, announced a sizable share repurchase program and drew higher price targets from other fir…
Guggenheim has lowered its price target for Humana to $252 from $312 but kept a Buy rating, citing an incremental $1 billion net Stars headwind for 2026 and the company’s planned 25% membership increase. Multiple brokerages have adjusted targets and ratings following Humana’s 2026 guidance and a low Medicare Advantage payment rate projection from C…
CFM, the joint venture between GE Aerospace and Safran, is formally studying a more traditional ducted fan engine architecture in addition to its preferred open-fan, or open-rotor, concept. The open-fan design is promoted under the RISE research programme as delivering about 20% fuel and emissions savings, but the newly revealed 'Advanced Ducted-La…
Zoetis stock climbed 3% after the company reported fourth-quarter adjusted EPS of $1.48, topping the LSEG consensus of $1.40. Management issued fiscal 2026 guidance with adjusted EPS of $7.00 to $7.10 and revenue guidance of $9.825 billion to $10.025 billion, both slightly ahead of Wall Street expectations. Some analysts highlighted that internatio…
Alphabet's Google Cloud is growing at AI-era speeds and materially improving cost efficiency. With Cloud at 48% YoY growth, massive cash flow, and a still-reasonable multiple for a re-accelerating growth engine, this trade idea buys the pullback in GOOGL for a 180-trading-day campaign. Entry, stop and target are provided along with catalysts and ba…
CK Hutchison Holdings Ltd. has notified A.P. Moller-Maersk A/S that it will pursue legal remedies if Maersk’s terminal arm moves to operate the Balboa and Cristobal ports without CK Hutchison’s consent. The move follows Panama authorities' invalidation of CK Hutchison’s contract to run the two ports, and Panama has indicated APM Terminals would man…
Shares of Dell and HP declined sharply after Lenovo warned that disruptions in memory supply and rising prices could affect the global hardware industry for a full year. Lenovo reported a 21% drop in December-quarter net income while revenue increased to $22.2 billion. The company said memory costs rose 40% to 50% in the last quarter and contract p…
Futures tied to Canada’s primary stock index moved modestly higher Thursday as market participants parsed a stream of corporate earnings and waited on additional U.S. economic data. The S&P/TSX 60 futures climbed by 3 points (0.2%) as the broader S&P/TSX composite retreated slightly from an earlier intraday peak. Technology losses, led by Shopify a…
Piper Sandler lowered its price target on American International Group (AIG) to $88 from $95 while retaining an Overweight rating. The firm pointed to better-than-expected catastrophe losses and favorable reserve development but said underlying underwriting results and top-line trends disappointed. InvestingPro data show AIG trading at $78.44 with …
Needham has trimmed its price target on Cellebrite to $18 from $24 while retaining a Buy rating. The adjustment arrives even as the digital intelligence company outperformed expectations on revenue, gross margins and annual recurring revenue growth. Management projects ARR growth of 18%–19% for calendar 2026, a figure Needham describes as a conserv…
Needham reduced its price objective on Unity Software to $35 from $50 while keeping a Buy rating, pointing to a lower valuation multiple even as the company’s Vector product reports double-digit sequential growth. Unity’s stock trades well below its 52-week high amid mixed earnings results, a decision to wind down the ironSource ad business, and lo…
Scotiabank raised its price target on Equinix to $997 from $959 while maintaining a Sector Outperform rating, pointing to a stronger backlog, planned site openings and increased enterprise AI deployments as drivers of faster earnings growth. Equinix’s updated 2026 guidance and recent revenue forecast, alongside third-party analyst reactions, provid…
Piper Sandler lowered its price target on HubSpot Inc. to $280 from $400 while retaining an Overweight rating, pointing to a compression in software sector multiples as the key driver. The research note acknowledged several favorable operating signals at HubSpot - including strong gross margins, accelerating net new ARR, revenue beats, a $1 billion…
KeyBanc has lowered its price target on ANGI Inc to $11 from $17 while retaining an Overweight rating, following the company's fourth-quarter results and revised 2026 guidance. Management now expects revenue growth to return later than previously forecast, and it has trimmed 2026 growth guidance from mid-single-digit to low-single-digit. The stock …
Piper Sandler reduced its price target for Inspire Medical Systems from $165 to $85 while retaining an Overweight rating, pointing to reimbursement uncertainty tied to the company’s Gen 5 device. Inspire delivered stronger-than-expected fourth-quarter results but lowered fiscal 2026 revenue guidance after a coding clarification that will affect phy…
Scotiabank reduced its price target on GFL Environmental to $56 from $57 while retaining a Sector Outperform rating, attributing the adjustment to foreign exchange headwinds reflected in GFL's 2026 guidance. The waste services provider posted stronger-than-expected fourth-quarter results and flagged continued commodity and FX pressures, while plann…
Scotiabank raised its price target on AppLovin Corp to $775 from $750 and retained a Sector Outperform rating after the company posted fourth-quarter results that topped expectations for revenue, EBITDA and EPS. While the bank highlighted margin expansion and a scheduled e-commerce platform launch in H1 2026, mixed first-quarter guidance and a vola…
Piper Sandler has increased its 12-month price target for Fastly Inc. (FSLY) to $14 from $11 while maintaining a Neutral rating. The research note highlights a sizable earnings beat, accelerating sales momentum driven by large customers and former Edgio accounts, and guidance that tops consensus for 2026. Analysts and market-data providers show imp…
PDD Holdings trades at $104.58 with a $145.9B market cap, a trailing P/E of 10.4 and a 52-week range of $87.11 - $139.41. Fundamentals and sentiment point to upside while technicals and short interest suggest a setup for a measured long trade. I recommend a long trade with an entry at $104.58, target $140.00 and stop loss $95.00 over a long-term (1…
Exelon reported fourth-quarter adjusted earnings above analyst expectations and raised its four-year capital expenditure plan to $41.3 billion from $38 billion. The Chicago-based utility said higher electricity rates and accelerating power demand supported the results and that it expects 2026 adjusted earnings of $2.81 to $2.91 per share, slightly …
PG&E raised the lower bound of its full-year 2026 profit outlook, citing strong power demand driven by data centers and broader electrification. The utility has moved additional data center capacity into final engineering and reiterated major transmission spending plans, even as quarterly adjusted earnings missed analyst expectations and shares dip…
Wells Fargo’s 2026 biotech outlook narrows its high-conviction SMID-cap ideas to six companies it expects to outperform based on near-term clinical readouts, regulatory milestones, and commercial rollouts. The bank’s coverage spans 22 names, but Ionis, Beam, Taysha, Sarepta, Spyre and RAPT stand out for their pipeline depth, upcoming data, and fina…
Clear Street has reduced the valuation it is seeking in its U.S. initial public offering to $7.2 billion from an earlier $11.8 billion target. The New York-based brokerage is offering 13 million shares at $26 to $28 apiece, down from an initial plan to sell 23.8 million shares at $40 to $44 each. The offering is expected to price later on Thursday,…
H.C. Wainwright increased its price target on NovoCure Ltd. (NVCR) to $47.00 from $39.00 and kept a Buy rating following FDA approval of Optune Pax for locally advanced pancreatic cancer in combination with gemcitabine and nab-paclitaxel. The approval arrived earlier than expected, prompting the firm to raise the probability of success in pancreati…
